Cargando…
The translation elongation factor eEF2 is a novel tumor-associated antigen overexpressed in various types of cancers
Recent studies have shown that cancer immunotherapy could be a promising therapeutic approach for the treatment of cancer. In the present study, to identify novel tumor-associated antigens (TAAs), the proteins expressed in a panel of cancer cells were serologically screened by immunoblot analysis an...
Autores principales: | OJI, YUSUKE, TATSUMI, NAOYA, FUKUDA, MARI, NAKATSUKA, SHIN-ICHI, AOYAGI, SAYAKA, HIRATA, ERIKA, NANCHI, ISAMU, FUJIKI, FUMIHIRO, NAKAJIMA, HIROKO, YAMAMOTO, YUMIKO, SHIBATA, SYOHEI, NAKAMURA, MICHIYO, HASEGAWA, KANA, TAKAGI, SAYAKA, FUKUDA, IKUYO, HOSHIKAWA, TOMOKO, MURAKAMI, YUI, MORI, MASAHIDE, INOUE, MASAYOSHI, NAKA, TETSUJI, TOMONAGA, TAKESHI, SHIMIZU, YOSHIFUMI, NAKAGAWA, MASASHI, HASEGAWA, JUNICHI, NEZU, RIICHIRO, INOHARA, HIDENORI, IZUMOTO, SHUICHI, NONOMURA, NORIO, YOSHIMINE, TOSHIKI, OKUMURA, MEINOSHIN, MORII, EIICHI, MAEDA, HAJIME, NISHIDA, SUMIYUKI, HOSEN, NAOKI, TSUBOI, AKIHIRO, OKA, YOSHIHIRO, SUGIYAMA, HARUO |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027928/ https://www.ncbi.nlm.nih.gov/pubmed/24589652 http://dx.doi.org/10.3892/ijo.2014.2318 |
Ejemplares similares
-
An Immunocompetent Mouse Model for MLL/AF9 Leukemia Reveals the Potential of Spontaneous Cytotoxic T-Cell Response to an Antigen Expressed in Leukemia Cells
por: Hasegawa, Kana, et al.
Publicado: (2015) -
Enhanced immune reaction resulting from co-vaccination of WT1 helper peptide assessed on PET-CT
por: Nakata, Jun, et al.
Publicado: (2020) -
Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptide
por: Oji, Yusuke, et al.
Publicado: (2016) -
WT1 Peptide Cancer Vaccine for Patients with Hematopoietic Malignancies and Solid Cancers
por: Oka, Yoshihiro, et al.
Publicado: (2007) -
WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1
por: Oji, Yusuke, et al.
Publicado: (2023)